|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2008-1-24
|
|
pubmed:abstractText |
To investigate the effect of early administration of granulocyte colony-stimulating factor (G-CSF) on hospital mortality in nonneutropenic patients with septic shock, excluding patients with melioidosis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1530-0293
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
36
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
448-54
|
|
pubmed:meshHeading |
pubmed-meshheading:18216600-Adjuvants, Immunologic,
pubmed-meshheading:18216600-Adult,
pubmed-meshheading:18216600-Aged,
pubmed-meshheading:18216600-Double-Blind Method,
pubmed-meshheading:18216600-Drug Administration Schedule,
pubmed-meshheading:18216600-Female,
pubmed-meshheading:18216600-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:18216600-Hospital Mortality,
pubmed-meshheading:18216600-Humans,
pubmed-meshheading:18216600-Intensive Care,
pubmed-meshheading:18216600-Length of Stay,
pubmed-meshheading:18216600-Male,
pubmed-meshheading:18216600-Middle Aged,
pubmed-meshheading:18216600-Recombinant Proteins,
pubmed-meshheading:18216600-Shock, Septic,
pubmed-meshheading:18216600-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Randomized, double-blind, placebo-controlled trial of granulocyte colony-stimulating factor in patients with septic shock.
|
|
pubmed:affiliation |
Intensive Care, Royal Darwin Hospital, Darwin, Australia. dianne.stephens@nt.gov.au
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
